Business
Hydreight Achieves 33% YoY H1 Revenue Growth, Records 3rd Consecutive Quarter of Profitability, and Strengthens Performance Across Verticals
“We had a great first 6 months, with 33% year-over-year growth. We have also exceeded our ...
About this update from Hydreight Technologies Inc
[{"type":"text","content":"Hydreight Achieves 33% YoY H1 Revenue Growth, Records 3rd Consecutive Quarter of Profitability, and Strengthens Performance Across Verticals\n\n\n\n\n “We had a great first 6 months, with 33% year-over-year growth. We have also exceeded our internal metrics across all verticals in the first seven months of the year, reinforcing the strength of our strategy. A key focus has been our investment in making the VSDHOne platform fully modular, allowing customers to adopt it module by module to fit their needs. At the same time, we’ve been prioritizing acquisitions and strategic investments that strengthen our margins, accelerate growth, and expand our ecosystem. These initiatives position us to scale efficiently and achieve our 2025 objectives.” – Shane Madden, CEO of Hydreight\n \n\n\n VANCOUVER, British Columbia and LAS VEGAS, Aug. 25, 2025 (GLOBE NEWSWIRE) --\n \n\n Hydreight Technologies Inc.\n \n\n (“\n \n Hydreight\n \n ” or the\n \n “Company\n \n ”) (\n \n\n TSXV: NURS\n \n\n )(\n \n\n OTCQB: HYDTF\n \n\n )(\n \n\n FSE: SO6\n \n\n ), a mobile clinical network and medical platform which enables flexible at-home medical services across 50 states in the United States, is pleased to announce its financial results for the second quarter ended June 30, 2025. All financial information is presented in Canadian dollars unless otherwise indicated.\n \n\n\n Q2 2025 Highlights\n \n\n\n\n\n Q2, 2025 GAAP revenue was $5.38 million an increase of 31% compared to Q2, 2024.\n \n\n\n\n Q2, 2025 topline¹ record revenue of $7.35 million, an increase of 31% compared to Q2, 2024.\n \n\n\n\n First 6 months GAAP revenue was $9.92 million an increase of 33% compared to the same period last year.\n \n\n\n\n First 6 months topline¹ revenue was $13.88 million an increase of 33% compared to the same period last year.\n \n\n\n\n\n Gross Margin of $1.93 million, up from $1.56 million in Q2 2024\n \n\n\n\n\n Adjusted EBITDA¹ of $182K for Q2 2025, marking continued operational improvement\n \n\n\n\n\n GAAP Net Income of 50K, from GAAP Net Loss of $27K in Q2, 2024\n \n\n\n\n\n Cash on Hand of $6.10 million at quarter-end\n \n\n\n\n\n Approximately 77% growth in new Nurse signup compared to Q2, 2024\n \n\n\n\n\n Approximately 48% growth in Number of pharmacy orders compared to Q2, 2024\n \n\n...